Infectious Disease and Microbiology – Loa loa

Overview

Loa loa is a filarial nematode that causes loiasis, also known as African eye worm disease. Infection is endemic in parts of Central and West Africa and is transmitted to humans by the bite of infected Chrysops deer flies.

Most infected individuals remain asymptomatic. Symptomatic disease classically produces transient angioedematous swellings called Calabar swellings and migration of an adult worm across the subconjunctival tissues of the eye.

Classification

Genus: Loa

Species: Loa loa

Type: Filarial nematode

Disease: Loiasis

Common name: African eye worm

Microbiologic Characteristics

L. loa is a:

• Tissue-dwelling filarial nematode

• Parasite transmitted by an arthropod vector

• Cause of chronic subcutaneous infection

• Producer of circulating microfilariae

Adult worms migrate through the subcutaneous tissues, whereas microfilariae circulate in the peripheral bloodstream.

Vector

The vector is an infected:

Chrysops deer fly

These flies are also called:

Deer flies or mango flies

Transmission occurs when an infected fly takes a blood meal and introduces infective larvae into the skin.

Transmission Cycle

Infected Chrysops fly bites human

↓

Infective larvae enter the skin

↓

Larvae mature into adult worms

↓

Adult worms migrate through subcutaneous tissues

↓

Females release microfilariae

↓

Microfilariae circulate in peripheral blood

↓

Another deer fly ingests microfilariae

Incubation and Development

Microfilariae may become detectable in peripheral blood several months after infection.

The source describes approximately:

4 months

as an early point at which microfilaremia or symptoms may appear.

However, symptomatic loiasis frequently develops only after:

Several years

This prolonged course reflects the chronic nature of filarial infection.

Epidemiology

Loiasis occurs primarily in:

Central and West Africa

particularly in forested regions where the Chrysops vector is present.

The source estimates that millions of people may be infected in endemic regions.

Clinical Infection

The disease caused by L. loa is:

Loiasis

Most infected people are:

Asymptomatic

When manifestations occur, they primarily result from migration of adult worms through subcutaneous tissues and the host inflammatory response.

Calabar Swellings

Classic Manifestation

One of the most characteristic findings is:

Calabar swelling

These are transient, localized areas of subcutaneous edema caused by the inflammatory response associated with migrating adult worms.

Clinical Features

Calabar swellings may:

• Appear suddenly

• Occur on different parts of the body

• Produce localized discomfort

• Cause pruritus

• Cause localized pain

• Persist temporarily and then resolve

• Recur at another location

The extremities are commonly affected.

Pathogenesis

Adult worm migrates through tissue

↓

Local inflammatory/hypersensitivity response

↓

Transient localized edema

↓

Calabar swelling

Eye Worm

Subconjunctival Migration

Another classic manifestation is migration of an:

Adult Loa loa worm across the conjunctiva

The worm may be directly visible moving beneath the conjunctival surface.

This striking finding accounts for the name:

African eye worm

Clinical Manifestations

Subconjunctival migration can cause:

• Foreign-body sensation

• Eye irritation

• Conjunctival inflammation

• Lacrimation

• Discomfort

Although dramatic, the worm’s passage across the eye is usually transient.

High-Yield Clinical Pattern

Patient from Central or West Africa

• ●

Recurrent transient localized swelling

• ●

Visible worm migrating across the conjunctiva

→ Think Loa loa

→ Diagnosis: Loiasis

Microfilariae

Diurnal Periodicity

A particularly important characteristic is:

Diurnal periodicity

Loa loa microfilariae are most abundant in peripheral blood during the:

Daytime

This corresponds with the daytime feeding behavior of the Chrysops vector.

Diagnostic Implication

Blood should therefore be collected during:

Daylight hours

Traditionally, collection around the middle of the day improves the likelihood of detecting microfilariae.

This is a major examination clue.

Diagnosis

Peripheral Blood Smear

The classic diagnostic method is:

Detection of microfilariae in peripheral blood

Because of diurnal periodicity:

Obtain a daytime blood sample.

Thick and thin blood smears can be examined microscopically.

Direct Visualization

Diagnosis may also be established by:

Visualizing an adult worm beneath the conjunctiva

This is a highly characteristic finding in the appropriate epidemiologic setting.

Tissue Examination

The parasite may occasionally be identified in:

Subcutaneous tissue

especially when a migrating adult worm is removed.

Serology

The source also lists:

Serologic testing

Serology can support the diagnosis but may have limitations in distinguishing among filarial infections, particularly in endemic areas.

Treatment

Diethylcarbamazine

The source identifies:

Diethylcarbamazine (DEC)

as the principal treatment for loiasis.

DEC has activity against:

Microfilariae

and can also have activity against:

Adult worms

Therefore, it has the potential to provide definitive treatment.

Major Treatment Danger

High Microfilarial Burden

Treatment of loiasis requires special caution because rapid killing of large numbers of microfilariae can provoke a severe inflammatory reaction.

This is particularly important in patients with:

High-grade microfilaremia

Encephalopathy

A major complication of treatment can be:

Severe encephalopathy/meningoencephalitis

which may be life-threatening.

The source particularly warns about careful supervision when microfilarial density exceeds approximately:

2,000 microfilariae/mL

The risk becomes especially concerning as microfilarial burden increases.

Treatment Principle

Before administering potent microfilaricidal therapy:

Diagnose loiasis

↓

Measure the peripheral microfilarial burden

↓

Assess risk of treatment-associated neurologic complications

↓

Select and administer therapy under appropriate supervision

This is one of the most important clinical principles in managing Loa loa infection.

Additional Treatment

The source lists:

• Ivermectin

• Albendazole

However, ivermectin requires particular caution because patients with very high Loa loa microfilaremia can develop severe or fatal neurologic adverse events following rapid microfilarial killing.

Albendazole has a slower effect on microfilarial levels and has been used in selected situations.

Surgical Removal

When an adult worm is accessible, such as beneath the conjunctiva, it may be:

Surgically extracted

Removal can relieve local symptoms but does not necessarily eliminate other adult worms or circulating microfilariae elsewhere in the body.

Loa loa and Onchocerciasis Treatment

A particularly important practical association is that Loa loa co-infection can complicate treatment programs for:

Onchocerca volvulus

Ivermectin is widely used against onchocerciasis, but a patient with heavy Loa loa microfilaremia may be at risk for severe neurologic reactions after ivermectin.

Therefore, in areas where both parasites occur:

Consider Loa loa burden before ivermectin treatment.

Loa loa vs. Onchocerca volvulus

Loa loa

→ Chrysops deer fly

→ Daytime microfilariae in blood

→ Calabar swellings

→ Eye worm crosses conjunctiva

→ DEC is an important treatment

→ High microfilarial burden creates treatment-related encephalopathy risk

Onchocerca volvulus

→ Blackfly (Simulium)

→ Microfilariae primarily in skin, not peripheral blood

→ Subcutaneous nodules

→ Dermatitis

→ Ocular disease and river blindness

→ Ivermectin is central to treatment

Loa loa vs. Wuchereria bancrofti

Loa loa

→ Chrysops deer fly

→ Diurnal blood periodicity

→ Calabar swelling

→ Subconjunctival adult worm

Wuchereria bancrofti

→ Mosquito vector

→ Classically nocturnal blood periodicity

→ Lymphatic filariasis

→ Lymphedema and elephantiasis

High-Yield Diagnostic Pattern

Central/West Africa

• ●

Chrysops deer fly exposure

• ●

Calabar swellings

• ●

Subconjunctival migrating worm

• ●

Diurnally periodic microfilariae in peripheral blood

→ Loa loa

Exam Essentials

Organism: Loa loa

Type: Filarial nematode

Disease: Loiasis

Common name: African eye worm

Geography: Central and West Africa

Vector: Chrysops deer fly

Major reservoir/host: Humans are important hosts in endemic transmission

Adult worms: Migrate through subcutaneous tissues

Classic swelling: Calabar swelling

Classic ocular manifestation: Adult worm crossing the subconjunctiva

Microfilariae: Circulate in peripheral blood

Periodicity: Diurnal

Best classic blood sampling: Daytime

Diagnosis: Peripheral blood smear, direct visualization/removal of adult worm, supportive serology

Primary source treatment: Diethylcarbamazine (DEC)

Additional source treatments: Ivermectin and albendazole

Major treatment danger: Encephalopathy with high microfilarial burden

Important ivermectin issue: Heavy Loa loa microfilaremia increases the risk of severe neurologic adverse reactions

Key clinical pearl: The classic triad for Loa loa is Central/West African exposure, recurrent Calabar swellings, and a migrating subconjunctival “eye worm.” Microfilariae demonstrate diurnal periodicity, so diagnostic blood should be obtained during the daytime. Always consider the microfilarial burden before microfilaricidal treatment because heavily infected patients can develop life-threatening encephalopathy.